With a solid first-quarter performance and improving visibility into the balance of the year, this life sciences company remains confident in its ability to deliver sustained, profitable growth and long-term value creation.
The company we are profiling today is Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI), a provider of critical products supporting the development of drug therapies, diagnostics, and novel vaccines, as well as research into human diseases. Its customers include biopharmaceutical companies, emerging biotech firms, life science research organizations, academic research institutions and diagnostic companies.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.